Earnings summaries and quarterly performance for Electromed.
Executive leadership at Electromed.
Board of directors at Electromed.
Research analysts who have asked questions during Electromed earnings calls.
Recent press releases and 8-K filings for ELMD.
Electromed, Inc. secures new $10 million credit facility
ELMD
Debt Issuance
- Electromed, Inc. (ELMD) entered into a Credit Agreement with BMO Bank N.A. on December 16, 2025.
- This agreement provides a $10,000,000 revolving line of credit that matures on December 16, 2026.
- Borrowings under the facility will bear interest at one-month Term SOFR plus 1.75%, payable monthly.
- The company is subject to financial covenants, including maintaining a minimum Fixed Charge Coverage Ratio of at least 1.20x and a Total Funded Debt to EBITDA ratio of not more than 2.50x.
- Concurrently, Electromed, Inc. terminated its existing credit facility with Choice Financial Group.
Dec 18, 2025, 9:46 PM
Electromed, Inc. Announces Strong First Quarter Fiscal 2026 Results
ELMD
Earnings
Share Buyback
Revenue Acceleration/Inflection
- Electromed, Inc. reported a 15.1% increase in net revenues to $16.9 million for Q1 FY 2026, marking its twelfth consecutive quarter of year-over-year revenue and net income growth.
- Net income for Q1 FY 2026 grew 44.9% to $2.1 million, or $0.25 per diluted share, while operating income increased 37.8% to $2.7 million.
- The company maintains a strong financial position with $14.1 million in cash and no debt as of September 30, 2025.
- Electromed's board of directors approved a $10 million stock repurchase authorization in Q1 FY 2026, with $1.0 million of common stock already repurchased during the quarter.
Nov 12, 2025, 9:07 PM
Electromed, Inc. Announces First Quarter Fiscal 2026 Results
ELMD
Earnings
Revenue Acceleration/Inflection
Share Buyback
- Electromed, Inc. reported strong Q1 FY 2026 results (three months ended September 30, 2025), with net revenues increasing 15.1% to $16.9 million and net income rising 44.9% to $2.1 million, or $0.25 per diluted share, marking its twelfth consecutive quarter of year-over-year growth in both metrics.
- The company's board of directors authorized a $10 million stock repurchase program in Q1 FY 2026, with $1.0 million of common stock repurchased during the quarter.
- Operationally, Electromed completed its manufacturing optimization plan and implemented a new CRM system, contributing to improved efficiencies and profitability.
- As of September 30, 2025, Electromed maintained a strong balance sheet with $14.1 million in cash, no debt, and $44.7 million in total shareholders' equity.
Nov 12, 2025, 9:05 PM
Electromed Reports Record Fiscal Q4 2025 Results
ELMD
Earnings
Revenue Acceleration/Inflection
Share Buyback
- Electromed reported record financial results for the fiscal fourth quarter and full year 2025, with Q4 revenue increasing 17.3% year-over-year to $17.4 million and diluted earnings per share rising to $0.25.
- The company achieved eleven consecutive quarters of year-over-year revenue and operating income growth, driven by strong performance in its Direct Homecare business and improved gross margin.
- Following the earnings announcement, Electromed's stock price rose 10% to $22.80 in after-hours trading.
- During fiscal 2025, Electromed repurchased shares of its common stock and initiated a manufacturing optimization plan expected to complete in fiscal 2026.
Aug 26, 2025, 8:32 PM
Electromed reports record Q2 2025 revenue and net income
ELMD
Earnings
Revenue Acceleration/Inflection
Share Buyback
- Electromed (ELMD) achieved record revenues of $16.3 million in Q2 FY2025, an 18.7% increase year-over-year, marking the ninth consecutive quarter of revenue and net income growth.
- The company reported record net income of $2.0 million, or $0.22 per diluted share, and record operating income of $2.5 million for the quarter ended December 31, 2024.
- Electromed ended the quarter with $16.2 million in cash and no debt, and repurchased approximately $4.5 million in shares during the six months ended December 31, 2024.
- Operational performance was strong, with annualized Home Care revenue per weighted average direct sales representative reaching $1,077,000, exceeding the target range, and significant growth in the Hospital segment (17%) and DME distributor revenue (188%).
Feb 11, 2025, 10:00 PM
Electromed Announces Record Q2 2025 Financial Results
ELMD
Earnings
Revenue Acceleration/Inflection
Share Buyback
- Electromed reported record revenues of $16.3 million for Q2 FY2025, an 18.7% increase year-over-year, marking the ninth consecutive quarter of revenue and net income growth.
- The company achieved record net income of $2.0 million and record diluted EPS of $0.22 for the quarter ended December 31, 2024.
- Growth was driven by a 15.2% increase in direct home care revenue to $14.6 million, 16.8% growth in hospital revenue to $723,000, and a 188% increase in home care distributor revenue to $807,000.
- Electromed ended the quarter with 54 direct sales representatives, aiming for 57 by the end of Q3 FY2025, and reduced inventory by 35% compared to Q2 FY2024.
- As of December 31, 2024, Electromed held $16.2 million in cash with no debt, and repurchased approximately $4.5 million in shares.
Feb 11, 2025, 10:00 PM
Quarterly earnings call transcripts for Electromed.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more